Breakthrough: FDA Greenlights Rapid Hepatitis C Test for Immediate Point-of-Care Diagnosis
Today, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert…
RNA Detection
Read More